PARENTS AGAINST LINDANE

LINDANE
Home
LINDANE
The Real Truth about lindane
Head lice news
About Me
Multiple Sclerosis
Poems and Thoughts
Tourette's Syndrome
Pope John Paul ll
Conway Twitty

banner.gif

                                   Parents Against Lindane


Contact: Pamela LaBrake                         For Immediate Release
email:hlabrake@yahoo.com


USE CAUTION WHEN TREATING HEAD LICE

With school just around the corner a reminder to parents and healthcare providers concerning the insecticide lindane.

In 2003 the FDA (Food and Drug Administration) added a blackbox warning to lindane shampoo and lotion. Lindane shampoo is a prescription treatment for headlice and lindane lotion for scabies.

A blackbox warning means that medical studies indicate a drug carries a significant risk of serious or life threatening adverse effects. It is the strongest warning that the Food and Drug Administration requires.

Young children, preschool through elementary age, are most prone to head lice infestation so the following information by the FDA cannot be stressed enough.

Lindane is contraindicated for use in neonates and should be used with extreme caution in children and in individuals weighing less than 50 kg (110 lbs). Among adverse event reports in which the outcome was serious (resulted in hospitalization, disability or death), the very young and the elderly appeared to be more susceptible to Lindane’’s adverse effects and had worse outcomes.
http://www.fda.gov/cder/foi/label/2003/006309shampoolbl.pdf

The risk of neurologic side effects associated with Lindane is known from clinical trials, spontaneous post-marketing reporting data and literature reports. These side effects have ranged from dizziness to seizures. In post-marketing reports, neurologic side effects occurred in patients who misused Lindane, as well as in patients who used Lindane according to labeled instructions. Among the adverse event reports in the FDA database, 70% reported neurologic events including seizure, dizziness, headache and paresthesia.

There are less toxic over the counter treatments. Most important is to get a good lice comb to remove lice and nits.

Dr. Greene has excellent information on his website on how to safely treat head lice with inexpensive ingredients, many found right in your home.

http://www.drgreene.com/21_640.html


Links for Parents and School Nurses

NY guide to getting rid of lice and nits
http://home2.nyc.gov/html/doh/html/scah/lice.shtml

Getting rid of lice naturally
http://www.wikihow.com/Get-Rid-of-Lice

A School's Guide to the 'Nitty-Gritty'
About Head Lice

http://pubs.caes.uga.edu/caespubs/pubcd/c850.htm


Provided via: http://www.i-newswire.com

EPA Bans Lindane-click on this link to read full text here !

Residents asked to avoid Lindane for treating lice

By Gene Deason - Brownwood Bulletin
Published: Monday, September 15, 2008 8:05 AM CDT
Area residents are being reminded that they have a variety of options other than Lindane, also known as Kwell, to treat lice, and those options are recommended by municipal officials to avoid wastewater contamination and violation of environmental regulations.

“This concern comes up every fall when school starts,” Dr. Jim Hays, medical director for the Brownwood-Brown County Health Department, said. “Children get back to school, and it seems there is usually an outbreak of head lice. Then, it seems a lot of students get a cold.”

Hays said environmental law states that any detectable amount of Lindane in municipal wastewater is considered to be a contaminant. However, detection methods have become so sophisticated since the law was written, that even trace amounts as small as one part per trillion can be isolated. In effect, any Lindane in the water is a violation.

Products used to kill lice are topical, and the medication - which is pesticide - gets washed down drains into wastewater systems.

“Most doctors don’t prescribe Lindane for lice any more,” Hays said. Physicians tend to specify treatments like Ovide, Nix or Rid instead, and those have proven to be effective.

Hays described the pesticide Lindane as “persistent,” meaning it lingers in the environment for a long period and sustains its toxic effect on wildlife and humans. The available alternatives are not “persistent,” he added.

The Agency For Toxic Substances and Drug Registry ranks lindane 33 out of 275 other substances on its Priority List of Hazardous Substances and the Environmental Protection Agency has severely restricted the use of Lindane as an agricultural pesticide due to Lindane’s adverse health effects, according to Lindane Education and Research Network, a project of the National Pediculosis Association.



Copyright © 2008 - The Brownwood Bulletin - Brownwood, TX

Safest treatment for headlice, a lice comb

3. Combing. Separate a mass of hair that is slightly wider than the width of the metal lice comb and about 3/4 inch in the other direction. It is important to separate the hair into small sections so you can more easily see lice and nits.

Hold the mass of hair with one hand. With the other hand, hold the lice comb in a slanting position with the teeth toward the head.

Insert the comb as close to the scalp as possible since the eggs are first laid within 1/2 inch of the scalp. Gently pull the comb slowly through the hair several times. Check the hair carefully.

Comb one section at a time and check each section again. Pin the hair out of the way curling it flat against the head. Whenever you comb out nits or live lice, dunk the comb in the soapy water. Make sure the comb is clean before you use it on the hair again. Frequently remove hair and other debris from the comb with a tissue. When the bowl is full, flush its contents down the toilet and refill the bowl with soapy water. Continue combing.

After Combing. Flush the contents of the bowl down the toilet. Shampoo the hair at least twice to remove the oil. When the hair is dry, check for stray nits and remove those hairs individually with a pair of small, pointed scissors.

http://lancaster.unl.edu/enviro/pest/factsheets/headlice018_99.pdf

MANAGEMENT OPTIONS

Lice can be controlled without resorting to shampoos with pesticide, but this depends on thorough combing of the hair with a special lice comb. Because reinfestation from playmates is common (regardless of the treatment used), parents may wrongly assume that the first treatment wasn’t strong enough and turn to something more toxic. To minimize reinfestation, schools are urged to adopt a "No Nit" policy (see below) and to educate teachers and students, but especially parents, in how to find, control, and prevent head lice.

Shampoos with Pediculicides

We do not recommend the use of insecticides except as a last resort in extreme cases. The scalp has many blood vessels that are close to the skin, making it easy for toxic substances to be absorbed directly into the bloodstream. Absorption is greater when the skin is warm and the blood vessels are dialated.

For many years, lindane (commonly referred to as Kwell®), an organophosphate pesticide, was the treatment of choice; it is still recommended by many medical personnel who have not taken the time to acquaint themselves with its potential health hazards to humans.

Lindane is absorbed through the skin into the bloodstream; once absorbed, it can be carried throughout the body to tissues and organs. In pregnant women, it can travel across the placenta to the developing fetus.

Lindane is available only by prescription. We do not recommend its use at any time. In many cases, its chronic overuse has produced resistant lice and rendered lindane ineffective.

This document was produced for USEPA (Document #909-B-97-001) by the Bio-Integral Resource Center, P.O. Box 7414, Berkeley, CA 94707, March 1997.

Comparative efficacy of two nit combs in removing head lice (Pediculus humanus var. capitis) and their eggs.

Speare R, Canyon DV, Cahill C, Thomas G.

Anton Breinl Center for Public Health and Tropical Medicine, School of Public Health , Tropical Medicine and Rehabilitation Sciences, James Cook University , Townsville , Queensland , Australia .

Background Fine tooth lice combs fall into two classes based on the material from which their teeth are made: plastic or metal. Metal combs are further divided into those that are made from a flat sheet of metal, and hence have rectangular teeth, and those that have cylindrical teeth embedded in a plastic base. Methods The efficacy of two fine tooth combs [Lice Meister comb (metal) and Lady Jayne comb (plastic)] in removing head lice (Pediculus humanus var. capitis) and their eggs from the hair of children was evaluated after treatment with a viscous head lice product (Lice Blaster; Emerald Forest Pharmaceuticals Pty Ltd, Currumbin, Qld, Australia). The hair of 27 children was divided into two sections sagitally, and each comb was randomly assigned to one half of the hair, and the lice and eggs removed by the combs were counted. Results In 96% of subjects, the Lice Meister comb removed more eggs than the Lady Jayne comb, with an average of three to four times more hatched, dead, and live eggs removed. The Lice Meister comb removed more lice than the Lady Jayne comb in 10 subjects, the same in eight subjects, and less in nine subjects. Conclusion Overall, the Lice Meister comb is recommended as a more effective comb for use in controlling head lice infestations, whether employed with conditioner or with insecticide treatment. This appears to be the first study investigating the efficacy of nit combs in vivo. Further research is needed to determine which characteristics of fine tooth combs are the most important in removing head lice eggs.

PMID: 18173523 [PubMed - in process]

Next time, just shave your head...at least you'll live through it...

By Thomas Keister

February 02, 2008

I have said for years that the Food and Drug Administration is, for the most part, worthless, a wind-sock in a land devoid of breeze. For every report of tainted Chinese crap hitting the mainstream media last year, I swear I could count three or four commercials touting some cockamamie (no pun intended) erectile dysfunction treatment or psuedo-trendy diet pill, carrying that world-famous disclaimer. You know the one, about how none of the statements in the ads have been "verified" by the Food and Drug Administration." Never have received an answer as to what it is the FDA is doing where they don't have any time left to raid the late-night medicine cabinet. To be fair, when the FDA more or less, sort of kind of gets one right, they deserve a little notice, more or less. Sort of kind of. In a letter the FDA issued in December, concerns were stated over the information Morton Grove Pharmaceuticals was using in web and print advertising of its head lice treatments containing lindane, an agricultural insecticide banned for use as such by the EPA in 2006. Morton Grove is the only manufacturer of lindane in the United States. I'm far beyond the point in my digestion of 21st century life where I question how a banned insecticide is useful as a scalp treatment, but there for the grace of blind consumerism, go I. Despite the fact that hospitalization, seizures, and even death have been reported from the use of Lindane Shampoo and Lindane Lotion, nearly ten percent of the prescriptions for head lice treatments written in 2007 were for lindane-based treatment, over 166,000. To clarify, the hospitalization, seizures, and death are listed on the warning label, by the FDA's own requirements. Ask your family doctor, just out of sheer morbid curiousity, what he or she would prescribe, and see what they answer. Be cure you have a Yellow Pages handy, just in case.

While Morton Grove Pharmaceuticals has suspended promotion of their Lindane products, at the request of the FDA, to allow the company time to develop new marketing materials, I find it a half-bubble past the center of sanity the products are even still allowed on the market. One of the statements the FDA, miraculously, took issue with was one by Morton Grove that the effective treatment requires two treatments. When the FDA calls something "extremely alarming," you know they have actually been paying attention, or at least we should hope... Morton Grove president/CEO Kurt Orlofski ventured beyond what I normally consider yes-holing, stating "the FDA has had a number of occasions to review the safety and efficacy of product and keep it or pull it: they have kept it on the market, it's an important second-line therapy." As I have mentioned in the past, the fact I have "Dr." in front of my name is irrelevant. I bought that honorary degree online for $40, fair and square, but I'm still willing to argue the importance of lindane as a treatment, and regardless of how many FDA yes-holes bleat in the background over how benefits outweigh risks, yeah, yes, hell yes I am willing to argue against rubbing a banned agricultural insecticide on some kid's scalp, anybody's scalp once, let alone a second time. When a government agency's standard operating procedure seems to land somewhere in the grey area between "what you don't know won't hurt you," and "what doesn't kill you, makes you stronger," then it seems even more so that arguments like mine are made for me.      American Chronicle Feb. 4, 2008

WRONGFUL DEATH VERDICT

JURY AWARDS $1,650,000.00 IN TOTAL DAMAGES

On March 2, 2007, a Talladega County jury returned a verdict for the Plaintiff in a medical malpractice case against a local physician and his employer, Baptist Health Centers, Inc. The jury found the healthcare providers liable for the death of a 6 ˝ month old child. The child died due to toxicity from Lindane, a medication used in the treatment of head lice and scabies. The jury found that the physician wrongfully prescribed the drug and/or inadequately instructed the mother with respect to use of the medication.

A set off of $1,150,000.00 was allowed against the verdict due to previous settlements with the manufacturer and the local pharmacy. The case was tried by Heninger Garrison Davis partner, Tim Davis and Talladega attorney, Steve Adcock.”

 

My heartfelt sympathies go out to the parent's and family of this baby.

EPA's own words on use of lindane for headlice and scabies

iv. Pharmaceutical use

Lindane is also used as a treatment for lice and scabies. Individuals who use lindane pharmaceutical products will be exposed to lindane in amounts that will exceed exposure from the seed treatment use. The pharmaceutical use, though, is also a source of exposure to the general population. EPA believes that lindane from the pharmaceutical use may reach drinking water via "down the drain" release; that is, lindane enters drinking water when individuals using the pharmaceutical products wash off their hands/bodies. Based on information from Los Angeles County, California, EPA estimated average effluent concentrations of lindane discharged from publicly owned treatment works to be 0.03 ppb (2002 RED at p. 23). In fact, California banned the pharmaceutical uses of lindane due to concerns about water contamination and acute neurotoxicity concerns from direct application. Although FDA has recommended that lindane be prescribed as a second line treatment since 1995, these products remain a source of exposure.

A. Presence of Lindane in Breast Milk

Although there currently are no programs in the United States for monitoring lindane levels in human breast milk, EPA believes that lindane is present in the breast milk of at least some nursing mothers in the United States. In general, lindane is very persistent and highly soluble in fat or fatty tissue. Therefore, it has the potential to bioaccumulate in the food chain and bioconcentrate in microorganisms, invertebrates, fish, birds, and mammals. In practical terms, this means that when women are exposed to lindane through food, water, or the atmosphere, they will accumulate lindane residues in their fatty tissue, including breast milk and breast milk fat, and that these lindane residues will remain there for an undetermined amount of time.2 Thus, to the extent women in the United States are exposed to lindane, EPA believes that that lindane likely will accumulate in their breast milk or breast milk fat.

Moreover, in the 1970s and 1980s, lindane was detected in breast milk in women in Binghamton, New York; Saint Louis, Missouri; several places in Mississippi, and in Philadelphia, Pennsylvania.

 

http://www.rsc.org/Publishing/ChemScience/Volume/2007/10/Contaminants_breast_milk.asp

Contaminants still present in breast milk

04 September 2007

Forty years after the lesson taught by the notorious pesticide DDT, it might be hoped that fat-loving toxins would have been eliminated from human tissues. However, a US study has shown that levels of some flame retardants and organochlorine pesticides in breast milk are still high enough to warrant concern, despite many of them having been phased out of use.

Kurunthachalam Kannan and colleagues from the New York State Department of Health, US, took breast milk samples from 38 mothers in the state of Massachusetts, and analysed them for various flame retardants and organochlorine pesticides, such as DDT and lindane. They found that although levels varied widely between individuals, there was a clear correlation between amounts of different contaminants. This suggests a common source of exposure, which is likely to be household dust or food, says Kannan.

The most prevalent contaminants in the samples studied, says Kannan, were polybrominated diphenyl ethers. These are flame retardants applied to household furnishings and electronic goods that are still widely used in many countries. The levels of these chemicals were between ten and 100 times higher than in Asian and European samples, which can be explained by the great market demand for them in the US, said Kannan.

The scientists point out that despite the continued presence of these contaminants, breast milk is still the best food for babies. Gina Solomon, senior scientist at the Natural Resources Defense Council, a US-based non-governmental environmental and health advocacy organization based in New York, agreed. 'The benefits of breast milk still outweigh any harm from these contaminants, and we must control or eliminate the chemicals rather than stop mothers from breast-feeding,' said Solomon.

Lindane use in geriatrics
 
 
Safety and efficacy of lindane have not been specifically studied in geriatric patients. Lindane shampoo and lotion should be used with caution in geriatric individuals since this age group may be at increased risk of serious neurotoxicity. There have been at least 4 reports of death in geriatric adults following application of lindane lotion for the treatment of scabies. Two of these patients died within 24 hours of application of the drug, one died 41 days after application and had a seizure on the day of death, and one died of an unreported cause of death on the day of treatment.
[McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006

In 2002 the FDA did a review of lindane, searching the Adverse Events Reporting System (AERS) database for reports of adverse events associated with lindane. From 1974 to 2002, there were 488 reports with the most common being "drug ineffective," followed by convulsions, dermatitis, and dizziness.

A review of the most serious cases described 15 deaths, 46 hospitalizations, seven life_threatening outcomes, and six cases of congenital anomalies.

http://www.michigan.gov/documents/EPI_insight_fall04_110950_7.pdf

One service-connected claim involving exposure to lindane was submitted to the Department of Veterans Affairs (VA) Board of Veterans Appeals. The initial claim was denied but was subsequently appealed. The appellant, the surviving spouse of a veteran, contended that her husband was exposed to various toxic chemicals, particularly lindane, during the Gulf War, and as a result of exposure to lindane, the veteran developed pancreatic cancer from which he subsequently died.

In the appeal, the Board considered scientific opinions presented on behalf of the appellant and by the VA. The scientific opinion on the behalf of the appellant maintained that lindane likely caused the veteran’’s cancer, while the VA did not recognize an association between lindane exposure in the Gulf and the veteran’’s cancer. The Board concluded that the preponderance of the evidence presented favored the appellant’’s claim. The Board found that it was "reasonably probable" that the veteran’’s pancreatic cancer, which caused his death, resulted from his exposure to lindane during the Gulf War. Therefore, the Board granted service connection for the cause of the veteran’’s death

http://gulflink.osd.mil/pesto/pest_s06.htm

EPA bans Lindane, now it's time for NY to ban it for headlice and scabies, and the FDA to ban it completely !!!
 

Citizens’ Environmental Coalition

Healthy Schools Network

Learning Disabilities Association of NYS

New York Public Interest Research Group

Parents Against Lindane

Pesticide Action Network of North America

MEDIA RELEASE

FOR IMMEDIATE RELEASE: FOR MORE INFORMATION CONTACT:

August 2, 2006 Laura McCarthy, Citizens’ Environmental Coalition 518-462-5527

Pam LaBrake, Parents Against Lindane 518-346-7190

Stephenie Hendricks, Pesticide Action Network 415-981-6205, x 309

EPA Announces Halt to Lindane for Ag Use

Risk to Children Remains through Pharmaceutical Products:

Groups Call for FDA, NYS to Ban All Use

 

(Albany) EPA today announced the withdrawal of all agricultural products in the U.S. containing the pesticide lindane. Environmental health groups around the country and in New York State applaud the step, but are critical of EPA’s claim to be the best agency in the world for pesticide regulation, and are calling for phaseout of the remaining uses of lindane.

All uses of lindane have already been banned in 52 countries around the world. Until today, the U.S. used up to 230,000 pounds of lindane yearly in seed treatment products, mostly on corn and wheat. The withdrawal allows continued use of existing stocks of lindane seed treatment products. Lindane use continues to be allowed for treatment of lice and scabies in pharmaceutical products regulated by the Food and Drug Administration (FDA).

 

"The phaseout of lindane’s agricultural uses is a long overdue step," says Bobbi Chase Wilding, Associate Director of Citizens’ Environmental Coalition, "We’re pleased the U.S. is finally moving to join the rest of the international community that has already stopped using this harmful pesticide. The FDA needs to follow suit so that no American is exposed to this highly toxic chemical. Since FDA has thus far refused, we call on the NYS legislature to act now to protect our children."

  

"It’s about time we stopped using this long-lasting, neurotoxic pesticide," says Kristin Schafer, Program Coordinator for Pesticide Action Network (PAN). "We’re pleased EPA has finally done the right thing – but this chemical linked to brain tumors and hormone disruption is still allowed in lotions and shampoos. We’re now asking for the public’s help to get FDA to withdraw lindane’s pharmaceutical uses."

-More-

Pharmaceutical uses of lindane for lice and scabies have been banned in California since 2002, and legislation promoting similar bans is moving forward in other states including Michigan and New York.

"Lindane is no longer allowed on pets or seeds, why are we still allowing use on kids?" asks Laura McCarthy, Program Associate with Citizens’ Environmental Coalition in Albany, New York. "We don’t need lindane. There are safer, affordable, more effective treatments available."

The New York State Legislature has bills (A.4162A and S.5619) pending in both houses. The groups called on State leaders to protect New Yorkers and to not wait for the FDA. The groups thanked Assemblymembers Weisenberg, Dinowitz, Ortiz, Perry, Espaillat, Arroyo, and Gottfried and Senators, Flanagan, LaValle, and Marcellino for their leadership as sponsors of this state legislation.

Lindane is a known neurotoxin that can cause seizures, damage the nervous system, and weaken the immune system. Exposure may also cause cancer and disrupt the human and animal hormone systems.

"When I found out that lindane was the source of my sons illness, my emotions ran the gamut from fear, to guilt, to anger that the FDA would allow this toxic pesticide to be used on children," said Pam LaBrake, a mother whose son suffers permanent effects due to lindane and who has been lobbying for the Lindane ban for the past eight years. "No other child and no other mother should have to suffer from exposure like this. A full ban of lindane in New York is a necessary next step."

In an E&E News story, Jim Gulliford, assistant administrator for EPA's Office of Prevention, Pesticides and Toxic Substances, explained why the agency chose to voluntarily cancel the chemical, stating that lindane "is recognized internationally as one of the most toxic, persistent, bioaccumulative pesticides ever registered."

The lindane news precedes the controversial announcement expected Thursday of EPA’s reregistration of more than 20 organophosphate and carbamate pesticides, despite strenuous objections voiced by thousands of EPA staff scientists who say these chemicals pose unacceptable risk to children’s health. In a news advisory released Tuesday, EPA highlighted lindane’s withdrawal (a 29 year process) and Thursday’s controversial reregistrations as evidence that "U.S. pesticide safety is the highest in the world." Public health and scientist advocacy groups staunchly disagree, and are calling for an end to industry pressure on EPA and FDA government scientists.

 

 

My heartfelt thanks to William for doing this informative and caring story.
Toxic consequences
Mom links son's condition to lindane, a lice treatment, and seeks to ban it
 
By William Brantley, Staff writer
First published: Tuesday, May 3, 2005

In the world of what would have been, her son Matthew would have started playing football this past year. His childhood dream was to play for the Dallas Cowboys.

Pamela LaBrake of Schenectady can picture in that world of what would have been how Matthew, who recently turned 15, would still be an outgoing, confident, happy kid with lots of friends and a smile big enough to make you do the same.

Instead of what would have been, LaBrake has managed to live with what is and what has been -- Matthew has been a quieter, more withdrawn boy with convulsive disorders and a variety of other health issues since soon after Dec. 18, 1997, when Matthew, then 7 years old, was sent home from school with head lice.

"I called (the doctor) and told them that he was 7," said LaBrake, recently, sitting in the den of her mother's house in Albany. "They prescribed a lindane shampoo. I picked it up within an hour."

Lindane is the common name for an organochloride pesticide known as gamma benzene hexachloride. Since the 1940s, it has been used in the United States as an agricultural insecticide and as a chemical treatment for lice and scabies.

In shampoo form, lindane is generally meant to be used only once, in a very methodical way, as a "second-line" treatment.

LaBrake found this out later. She said that because she hadn't received any explicit special instructions for using lindane, she figured she'd use it on Matthew just like any other shampoo. That's what she did.

The problems started a few weeks later. Matthew's eyes were swollen and red. They rolled around in his head. He was struck by twitches and spasms.

The first doctor who saw Matthew, in early January 1998, found a scraped cornea and diagnosed him with conjunctivitis.

At that point, LaBrake hadn't considered a correlation between Matthew's problems and the lindane shampoo. That changed a couple of months later, when she saw a television news report about the possible side effects of lindane.

"It was like they were describing Matthew," said LaBrake. "Oh my god, I knew right away."

Finding out

From that point on, LaBrake began to find out everything she could about lindane. She filled notebooks and folders with information about the pesticide.

She got in touch with doctors, pharmacies, legislators, other parents, the U.S. Food and Drug Administration, the Environmental Protection Agency and organizations trying to get the substance banned.

She filed Freedom of Information requests, posted letters on Internet message boards and watched, guilty and helpless, as Matthew's condition immediately worsened, then refused to go away.

In September 1998, nine months after LaBrake used the lindane, a neurologist saw Matthew and concluded in his report that the boy's symptoms were "consistent with the syndrome of acquired epileptic aphasia," a convulsive condition. Later, he would receive other diagnoses: epileptic encephalopathy, cortical irritability, cerebral dysfunction.

Going through changes

After a while, it didn't matter to LaBrake what they called it. The worst part was watching her son and realizing he might not ever be the same again.

He withdrew from other kids. He quit playing sports. He began dreading school.

"He remembers how he was before," said LaBrake. "When he was younger, he used to say, 'Why did you use that shampoo on me?' He doesn't say that anymore."

Although LaBrake is not taking any legal action regarding her own son's case, she has spent the past eight years actively seeking a ban on lindane.

Today, a child is less likely to receive a lindane shampoo prescription to treat head lice.

A little more than two years ago, the Food and Drug Administration issued a public health advisory concerning the use of lindane shampoo and lotion. It required lindane shampoo and lotion bottles to come with a "black box" warning highlighting the risks associated with the products.

"While FDA believes that the benefits of lindane outweigh the risks when used as directed, given the potential for neurotoxicity, patients should only be treated with these medications if other treatments are not tolerable or other approved therapies have failed," the March 28, 2003, advisory stated.

New advisories

In addition to stressing the use of lindane as a "second-line therapy," in essence a fall-back option when nothing else has worked, the FDA advised caution in using lindane on anyone weighing less than 110 pounds. "These warnings," the advisory read, "are based on reports to the FDA's voluntary reporting system, which described approximately one half of reported adverse events occurred in pediatric patients."

The advisory also stressed that each new prescription of lindane shampoo or lotion must be accompanied by a "Medication Guide" spelling out the instructions for use and the information about the possible side effects of lindane.

For some, this warning isn't enough.

In 2000, California became the first and, so far, only state to ban the use or sale of lice and scabies treatments using lindane. That bill cited not only the health concerns associated with the direct use of lindane but also the toxic polluting power of lindane being flushed into the water system because it is still used in agriculture.

A similar bill has been passed by the state House of Representatives in Illinois. A hearing on the bill is scheduled to take place Wednesday in the Health and Human Services Committee of that state's Senate.

The state of law

In New York, Assemblyman Harvey Weisenberg of Long Beach has sponsored a bill to ban lindane. He said he first became aware of lindane because a constituent suffered brain damage after using it.

"The evidence has proven that lindane is not only detrimental to the person who's using this product but also to the environment," said Weisenberg. "It has a warning on it (to) not use it on animals. If we don't use it on animals, why the hell would we use it on a child? It just doesn't make any sense."

The bill has been put on the committee's agenda for next Tuesday, May 10.

A number of public interest groups, including the Citizens' Environmental Coalition, the New York Public Interest Research Group, Physicians for Social Responsibility and the Healthy Schools Network have voiced strong support for the ban on lindane.

The ban seems to make sense, said Erin Cinelli, a pharmacist and adjunct faculty member in the department of pharmacy practice at the Albany College of Pharmacy. "You don't really see it too much anymore, anyway. I've only dispensed it once," said Cinelli.

"There are the over-the-counter (head lice treatments), and I'm a big advocate of doing all the manual things, like combing."

Upon hearing last week that the lindane bill was scheduled to be on the agenda soon, LaBrake was excited.

"I didn't want to get Matthew's hopes up, so I explained to him that it has to go through all these different committees and who knows what will happen," said LaBrake. "I told him that it was a good first step, though. He doesn't talk much, so he didn't say anything. But when I told him, he did sort of have this little smile."

MORE INFORMATION

* For the U.S. Food and Drug Administration's FAQ on lindane shampoo and lotion, visit http://www.fda.gov/cder/drug/infopage/lindane/lindaneQA.htm

* For the U.S. Environmental Protection Agency's fact sheet on lindane, visit http://www.epa.gov/REDs/factsheets/lindane_fs.htm

* For the Centers for Disease Control and Prevention fact sheet on head lice, visit http://www.cdc.gov/ncidod/dpd/parasites/headlice/factsht_head_lice.htm

* For more information about head lice and head lice treatments, visit http://www.nlm.nih.gov/medlineplus/headlice.html

* For more information about head lice and lindane, visit the Web site of the National Pediculosis Association at http://www.headlice.org

* The text of the bill sponsored by Assemblyman Harvey Weisenberg in the state Assembly Health Committee is available at http://www.assembly.state.ny.us/leg/?bn=04162

* For the Web site of Morton Grove Pharmaceuticals, the manufacturer of lindane shampoo, visit http://www.mgp-online.com/

* For the Web site of the Ban Lindane Campaign, vist http://www.pan-uk.org/banlindane/


All Times Union materials copyright 1996-2005, Capital Newspapers Division of The Hearst Corporation, Albany, N.Y.

I want to thank W. Steven Pray Ph.D., D.Ph for writing this informative and supportive letter.

April 12, 2005

Dear Assemblyman Gottfried:

I understand that New York is contemplating a bill that would ban lindane. I am in support of this bill as a pharmacist and as an expert in nonprescription products.

I have written four textbooks on nonprescription products, several book chapters, and over 250 papers for the pharmacy, medical, and dental hygiene literature. I have presented educational programs across the United States. One of my areas of specific expertise is the treatment of head louse infestation.

For many years, I have written and taught about the dangers of lindane and other topical pesticides traditionally used for head lice. In a speech entitled, "Alternative Lice and Scabies Treatment and Prevention Measures," I presented less toxic alternatives to lindane on behalf of the Environmental Protection Agency at the 2004 North American Commission for Environmental Cooperation meeting in Anchorage, Alaska. My paper covering this meeting was not published by one pharmacy journal for fear of losing support from advertisers. It can be accessed at: http://www.headlice.org/news/2005/growingmenace.htm

While all pesticides are potentially harmful when applied to humans, lindane has unique qualities that justify a worldwide ban on its use.

1. It is the most toxic head louse alternative, in terms of potential for human morbidity.

2. Resistance to lindane is widespread. For a succinct discussion of the problem, see my research paper at www.factsandcomparisons.com/ assets/hospitalpharm/mar2003_peer3.pdf

3. There are safer alternatives for scabies.

4. Lindane is a persistent environmental toxin.

The manufacturers of all pesticides possess the resources to ensure that toxic ingredients such as lindane remain on the market, squelching any attempt to remove them. Merely requiring a black box on lindane allows this noxious chemical to remain on pharmacy shelves around the state. You can take a great step forward in improving the health of your citizens by banning lindane from New York.

Sincerely,


W. Steven Pray, Ph.D., D.Ph.
Author, Nonprescription Product Therapeutics
Bernhardt Professor of Nonprescription Drugs and Devices
College of Pharmacy
Southwestern Oklahoma State University
Weatherford, OK 73096
steve.pray@swosu.edu
(580) 774-3257

Submission of Information on Lindane

Pursuant to Article 8 of the Stockholm

Convention as specified in Annex E of the Convention

Introductory information

Name of the submitting Party/Observer

NGO Observers: Alaska Community Action on Toxics (ACAT) and Pesticide Action

Network North America (PANNA) on behalf of the International POPs Elimination

"The Los Angeles County Sanitation Districts calculated that a single treatment for head lice, when rinsed down the drain, contributed enough lindane to the water entering treatment facilities to bring 6 million gallons of water over the CTR standard. Based on a review of California pesticide applicator records and physician surveys conducted by these same districts, there were no significant agricultural sources in the region, indicating that nearly the entire load was the result of pharmaceutical use.

Initially, an education campaign with pharmaceutical lindane providers was started to discourage use. While this appeared to decrease the inflow levels of contamination, it was inadequate to comply with the new standards. A bill was then sponsored in the California assembly, which passed without opposition, to ban the sale of all pharmaceutical lindane in the state of California beginning in Jan 2002.

"Although no systematic evaluation of the consequences of the California ban on lindane in head lice and scabies treatments has been conducted to date, an anecdotal survey of medical and public health authorities conducted by the Los Angeles County Sanitation Districts noted no difficulties or concerns that have been raised by the ban after over two years in a population of over 30 million. Lindane concentrations in wastewater exiting these Districts' treatment plants have declined from non-attainment of the 19 ppt goal to negligible following the 2002 institution of the ban on pharmaceutical sales."



By LAURAN NEERGAARD The Associated Press 3/28/03 5:00 PM WASHINGTON (AP) -- Using too much Lindane to treat lice infestations can cause deadly
brain or nerve damage, federal health officials warned Friday, stressing that the prescription drug should not be used on babies and "with great caution" on children.
The Food and Drug Administration took new steps to limit how much of the controversial drug people can slather on: Once sold in large bottles, Lindane now is to
come only in 1- or 2-ounce packets for one-time use, and doctors are told not to prescribe more. Lindane is an agricultural insecticide on which the Environmental
Protection Agency imposes strong restrictions. Less-potent versions are sold as creams and shampoos to be rubbed into the scalp and skin to treat lice and scabies,
a similar parasitic infection. Sold since the 1950s, they bear warnings that they can cause potentially fatal neurologic damage. Because safer treatments exist, the
FDA said in 1996 that Lindane should be prescribed only to patients not helped by safer alternatives and warned against overuse. Lindane is absorbed through the
skin, and slathering on too much, or using it more than once, greatly increases the risk. While Lindane use has dropped, from 1.8 million prescriptions in 1997 to
fewer than 1 million last year, people still misuse the drug, FDA's Dr. Sandra Kweder said Friday. Of 17 reported deaths associated with Lindane use, Kweder
cited two confirmed since 1996: a child given a too-high dose and an adult who applied Lindane repeatedly. Typically, someone who still itches has ample Lindane
left after the first application and ignores the doctor's advice to use it only once -- not realizing that the increased itching could signal that the parasites are dying,
Kweder said. So Friday, the FDA limited the amount patients can buy to a single dose. The agency also put its strongest warning on Lindane, stressing it's not for
babies and must be used with great caution in anyone else weighing under 110 pounds. Even then, it should be used only after other treatments have failed. The
patient advocacy group Public Citizen criticized the FDA, saying effective alternatives such as over-the-counter Nix are so much safer that Lindane should have been
banned.

SA bans farm use of Lindane

By Sheree Bega

The neurotoxin Lindane, the active ingredient in a controversial anti-lice shampoo, is to be banned in South Africa for agricultural use early next year.

Lindane is also known as Gamma Benzene Hexachloride.

Gerhard Verdoorn, spokesperson for the Association of Veterinary and Crop Associations of SA, said the department of agriculture had banned all pesticide formulations containing Lindane for agriculture, garden, home and public health use by March 2009, because it is a persistent organic pollutant and "doesn't fit into modern pesticide science any longer".

"The product will thus be banned from being manufactured, sold, disposed of and used by any individual or institution," he said.

"It scares me to think that the pesticide industry and the department have taken definitive action on a pesticide, and yet it's still an over-the-counter drug available to the public, in particular as a medicinal remedy for children.

"This product should be taken off the shelves immediately by the department of health."

Another lice shampoo sold locally, Quellada, also contains Lindane.

Mukesh Dheda, the national pharmaco-vigilance coordinator at the health department, said an investigation into the use of the product is currently being carried out, and the package insert is being reviewed.

"Priscilla Sehoole, spokesperson for the agriculture department, said: "South Africa is a member of the Stockholm Convention on Persistent Organic Pollutants (a global treaty to protect human health and the environment from dangerous chemicals) and "therefore deems it fit to abide with this decision to ban it".



  • This article was originally published on page 3 of Saturday Argus on November 08, 2008

Lindane (HCH) is banned or restricted in many countries, BUT is still used for headlice and scabies in the United States
 

HCH
Argentina, Austria, Bangladesh, Belize, Benin, Bolivia, Brazil, Bulgaria, China, Colombia, Cuba, Cyprus, Denmark, Dominican Republic, Ecuador, Egypt, Fiji, Finland, France, Germany, Greece, Guatemala, Honduras, Hong Kong, Hungary, Ireland, Israel, Ivory Coast, Jamaica, Japan, Jordan, Kenya, Korea, Liechtenstein, Luxembourg, Madagascar, Mauritania, Mexico, Moldova, Mozambique, Netherlands, Nicaragua, Panama, Paraguay, Peru, Philippines, Portugal, Singapore, South Africa, Spain, Sri Lanka, Sweden, Taiwan, Thailand, Turkey, United Kingdom, United States, Uruguay.

Lindane
Argentina, Australia, Bangladesh, Belgium, Belize, Bolivia, Brazil, Bulgaria, Chad, Colombia, Cyprus, Denmark, Dominica, Dominican Republic, Ecuador, Egypt, Finland, Guatemala, Honduras, Hong Kong, Hungary, Indonesia, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Korea, Lebanon, Madagascar, Mauritania, Moldova, Mozambique, Netherlands, New Zealand, Nicaragua, Paraguay, Philippines, St. Lucia, Singapore, Sri Lanka, Sweden, Switzerland, Taiwan, Tonga, Venezuela, Yemen.

Morton Grove Pharmaceuticals files lawsuit against Ann Arbor's Ecology Center stating the ecology center made misleading statements about lindane.

I commend the Ecology Center for standing their ground and fighting this frivolous suit, as they have only stated the true facts about lindane.

Morton Grove claims they have lost in excess of $75,000 as a result of "false and misleading " statements made by the defendants.

But the Ecology Center’s research is thoroughly supported in peer reviewed journal articles and government data.

On Morton Grove’s website they are the ones with misleading and false information. They have not stated that the EPA has BANNED lindane for agricultural use. They only say that the EPA feels it is safe for head lice and scabies when the EPA has no say on "medications".

Morton Grove claims they have lost $75,000, but they don’t state how they have already paid out over $90,000 to a lobbyist in Albany, NY to fight the lindane bill, and this doesn’t take into account the extra costs for phone bills and taking members of the assembly/senate out to lunches etc.

Will Morton Grove go after every agency, organization and parent who knows that lindane is the least effective and most toxic pesticide used on headlice and scabies?

I hope so.

Because not only will they have to pay out much more money then they claim they are losing, but this will backfire on them.

Because with the media attention this is getting, many more parent’s, school nurses, pediatricians and politicians will be educated with the correct facts that lindane should have been banned long ago, now that the the EPA has banned it there will be pressure for the FDA to follow, and our elected officials in our state governments will have to decide if they want to protect our children’s health, instead of being taken out to lunch.

Here is how the FDA, its advisories and doctors are "supposedly" putting our childrens health first regarding medication safety. This meeting focused on steroidal dermal medications for children, but can be applied towards any medication applied to our children's skin. I think any parent will be appalled at what they read. These are items I highlighted, the actual text is very long, will furnish link if you email me.

FOOD AND DRUG ADMINISTRATION

CENTER FOR DRUG EVALUATION AND RESEARCH PEDIATRIC ADVISORY SUBCOMMITTEEOF THE ANTI-INFECTIVE DRUGS ADVISORY COMMITTEE 8:06 a.m.Wednesday, October 29, 2003

It's been estimated that the FDA receives somewhere between 1 to 30 percent of adverse event reports, but there's just really no way of knowing what we're receiving. Thinking about it, I consult frequently in the ICU. Topical products are typically not asked for in the medication history by physicians in practice. So as a non-dermatologist, I think we routinely, even people in academic medical centers, don't pay any attention to topical medication.

As someone who recertifies in pediatrics and pediatric pulmonology and serving on this committee, I'm almost amazed at the lack of drug-related questions on board exams. One mechanism __ if more questions about drug reactions or drug toxicity were put into professional recertification exams, it would force physicians to raise their interest in that subject because I think the average practitioner gets most of their information from the detail person and probably does not read the package insert before they prescribe a drug.

Just basically I'm saying this for the recorder here. The younger pediatric patients have a larger surface area to mass ratio when compared to adults and may be at greater risk of higher systemic exposure to topically applied drugs. A statement of fact.

DR. FOST: You're asking whether there may be long-term toxicities that we'll never know about.

DR. TEN HAVE: Yes, and the question you asked. I think everybody is concerned about long-term use and less concerned about the short-term use that the current studies are addressing.

But then the last point is that whatever we do with the label in the box, that's not where it's at. Most of us never read those. The patients never read those, or not very often and don't know how to interpret because they're rats and dogs and birds and stuff.

DR. CHESNEY: Just to bring it to your attention or this may not have been __ I think the label in the box they just don't read. So unless the provider explicitly states it __ and many of us as providers didn't really think or weren't paying enough attention to this issue.

DR. GORMAN: I think the focus of what I would hope would be a patient package piece of information and not the mandated, got to be given out, is that just because it just goes on your skin doesn't mean it doesn't have effects on the rest of your body because I think that would apply for a lot of dermatological products besides just steroids. It would then focus on the fact that this has systemic effects __ excuse me __ has potential systemic effects.

DR. WILKIN: I think Dr. Schneider has made the point on several occasions, and I'd just like probably a highly reductive reiteration. So one of the key messages to our group is that the topical delivery is the part that isn't getting through to clinicians, anesthesiologists, internists, folks in emergency rooms, perhaps even pediatricians and dermatologists that topically applied products can have systemic effects. That seems to be a theme that would go beyond corticosteroids that we need to think about for some of our other products as well.

Like I said this is a very small part of the meeting, but I found it very disturbing that doctors do not read the inserts, and admit probably most parents dont. And that only 1% to 30% of adverse effects of medications are reported. So this very much applies to Lindane, as well as any other medication applied to the skin.

Links Button

The best site to learn alot about Lindane

Click here to learn all about headlice and the safest way to get rid of them

Non toxic lice treatments and education

Please click here to read about my son Matthew and how lindane has affected him neurologically. There are also other stories about other children and my heart goes out to them and their parents.

A DANGEROUS PESTICIDE
Red Growing Hazardous Material Symbol
STILL PRESCRIBED FOR OUR CHILDREN FOR HEADLICE

Animated Mailbox Opening and Closing

Click here to get in touch with me